3
Announcements
Trials
Browse
Landscape
Status
Completed
6
Unknown
4
Recruiting
2
Active not recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
169
Observational
2
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Unresectable Hepatocellular Carcinoma
1
Small Cell Lung Carcinoma
1
Interventions
Surveys and Questionnaires
39
Blood Specimen Collection
23
Specimen Handling
14
Radiotherapy
12
Surgical Procedures, Operative
10
Magnetic Resonance Spectroscopy
10
Interviews as Topic
10
Observation
9
Drug Therapy
9
Data Collection
8
Immunotherapy
7
Watchful Waiting
5
Tomography, X-Ray Computed
5
Radiosurgery
5
Nivolumab
5
Mental Status and Dementia Tests
5
Mastectomy, Segmental
5
Immune Checkpoint Inhibitors
5
Biopsy
5
ribociclib
4
palbociclib
4
lorlatinib
4
Therapeutics
4
Positron Emission Tomography Computed Tomography
4
Magnetic Resonance Imaging
4
Ipilimumab
4
High-Throughput Nucleotide Sequencing
4
Hepatectomy
4
Echocardiography
4
Bevacizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Observational
×
durvalumab
×
Clear all
NCT06117891
2026-05-12
REFINE-IO
Bayer
Active not recruiting
300 enrolled
NCT05683977
2026-02-24
ARSENAL
AstraZeneca
Active not recruiting
254 enrolled